Skip to Content

Vynleads Inc Ordinary Shares VYND

Morningstar Rating
$0.04 −0.51 (92.06%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

VYND is trading at a 56% discount.
Price
$0.04
Fair Value
$4.19
Uncertainty
Extreme
1-Star Price
$4.98
5-Star Price
$6.33
Economic Moat
Tmjsqw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if VYND is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.55
Day Range
$0.040.04
52-Week Range
$0.040.66
Bid/Ask
$0.02 / $0.40
Market Cap
$506,680.57
Volume/Avg
250 / 250

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Vynleads Inc is a provider of health and wellness information for people who are pre-diabetes or who have type 2 diabetes. Its core product is Done With Diabetes, which helps families manage, control, and prevent type 2 diabetes by providing them education, information, tools, and resources on an all-inclusive science-based platform. Its other product is Lifestyle Blueprint, a digital guide that provides dietary recommendations for a very low-calorie eight-week diet together with information focusing on what, how, and how much a person eats, nutritional information, and how a person's body does and does not use food to enable its customers to continue a more successful lifestyle.
Sector
Healthcare
Industry
Health Information Services
Stock Style Box
Total Number of Employees
1

Valuation

Metric
VYND
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
VYND
Quick Ratio
0.03
Current Ratio
0.05
Interest Coverage
−9.09
Quick Ratio
VYND

Profitability

Metric
VYND
Return on Assets (Normalized)
−994.12%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
VYND
See how this stock stacks up to its competitors with Morningstar Investor

Health Information Services Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
GEHC
GE HealthCare Technologies Inc Common StockSdpdlbm$39.4 Bil
VEEV
Veeva Systems Inc Class AKwmtssfkLtrj$32.4 Bil
SOLV
Solventum CorpGfhmmz$11.0 Bil
MTHRF
M3 IncQwcsqg$8.3 Bil
MTHRY
M3 Inc ADRLqdjpx$8.2 Bil
PMCUF
Pro Medicus LtdSrktvw$7.2 Bil
HQY
HealthEquity IncTcbvvlr$6.8 Bil
RCM
R1 RCM IncVqp$5.0 Bil
DOCS
Doximity Inc Class AVtxfmlz$4.5 Bil
EVH
Evolent Health Inc Class AGzgtd$3.3 Bil

Sponsor Center